FDA Requests New Studies for Amylin Pharmaceuticals, Inc.'s (JOBS) on Diabetes Drug, Byetta

Reuters -- The shares of Amylin Pharmaceuticals Inc fell nearly 10 percent on Wednesday after the U.S. Food and Drug Administration requested that the company conduct additional safety studies on its diabetes drug, Byetta.